Here are the four additions:
1. Laurie Huard, now the company’s COO, previously served as the vice president of operations at Helomics, a molecular diagnostics company focused on personalized healthcare.
2. Karol Ford, now the company’s vice president of sales and marketing, previously worked with Progenity, a genetics reference laboratory.
3. Tania Obranovich, PhD, now the company’s vice president of intellectual property, legal affairs and compliance, previously practiced as a partner at an intellectual property firm in Australia.
4. John Alsobrook II, PhD, now the company’s clinical laboratory director, previously served as the chief science officer at DermTech, a molecular diagnostic dermatology company.
Clinical Genomics is gearing up to launch a two-gene circulating tumor DNA blood test for postoperative monitoring of colorectal cancer.
More articles on health IT:
Hays Medical Center upgrades to MEDITECH’s web-based EHR
Dapasoft launches clinical data integration engine Corolar Cloud
AHA launches MACRA implementation tool
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
